Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Mf6.0
Methylfolat – Forschung
Hilft wahrscheinlich
66 begutachtete Studien
Was die Evidenz sagt
Hilft wahrscheinlich
Methylfolat scheint in 13 von 15 Studien mit messbaren Effekten zu helfen — die Evidenz tendiert klar ins Positive.
Die meiste Evidenz stammt aus hochwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 1990–2026 mit einer typischen Studiengröße von 73 Teilnehmenden.
Basierend auf 66 Studien · 6 Meta-Analysen · 41 RCTs · 11,874 Teilnehmende insgesamt
Konfidenz
Hohe Konfidenz
Was die Studien gefunden haben
13geholfen1unklar1nicht geholfen· 51 weitere ohne bewertete Effektdaten
Nach Outcome
Depression & moodFolat unterstützt den Homocystein-Stoffwechsel, der für die kognitive Gesundheit entscheidend ist · 4-8 Wochen
Hilft wahrscheinlich52 Studien
Therapeutic & clinical
Hilft wahrscheinlich24 Studien
Heart & blood pressure
Hilft wahrscheinlich16 Studien
Women's healthKlareres Denken durch Unterstützung der Neurotransmitter · 2-4 Wochen
Überwiegend Mechanismus / Beobachtung11 Studien
Cognitive functionFolate supports homocysteine metabolism critical for cognitive health · 4-8 weeks
Überwiegend Mechanismus / Beobachtung4 Studien
Safety profile
Überwiegend Mechanismus / Beobachtung4 Studien
Folate deficiency & anemia
Überwiegend Mechanismus / Beobachtung3 Studien
Neuroprotection & brain agingLiefert essenzielle Nährstoffe für eine gesunde Schwangerschaft · Fortlaufend
Zu wenige bewertete Studien1 Studie
Fertility & reproductiveVerbesserte Stimmung, insbesondere bei vorhandener MTHFR-Variante · 2-4 Wochen
Zu wenige bewertete Studien1 Studie
Inflammation
Zu wenige bewertete Studien1 Studie
In Zahlen
Aus 31 Studien mit messbaren Effekten gezogen
Wahrscheinlich echte Effekte
71%
über Studien hinweg
Untersuchte Personen
12k
typische Studie: 73 Personen
Stärkste Designs
47
6 gepoolt, 41 randomisiert
Zeigte Nutzen
87%
13/15 Studien
Wie lange Studien liefen
1–4 Wochen
1
1–3 Monate
2
3+ Monate
4
Untersuchte Populationen
Patients with peripheral arterial disease2
Patients with major depressive disorder2
Pregnant women2
Adults with major depressive disorder1
Aktives Forschungsgebiet
27 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2022
199020082026
1Systematische Übersichtn=2,256 · very large study2023
Einfach gesagt: As for anxiety symptoms, the availability of results is limited to adjuvant vitamin D therapy.
Borges-Vieira JG et al. · Nutritional neuroscience (2023)
2Depression response (Hamilton Rating Scale for Depression-17)Meta-Analysen=6,707 · very large study2022
Einfach gesagt: Adjunctive L-methylfolate may have modest efficacy in antidepressant-treated adults with MDD.
Maruf AA et al. · Pharmacopsychiatry (2022)
Groß Schaden
← SchlechterKein EffektBesser →
Likely real
In the meta-analysis of categorical Hamilton Rating Scale for Depression-17 response, (three studies, N=483) adjunctive L-methylfolate was associated with a small effect versus antidepressant monotherapy (relative risk: 1.25, 95% confidence interval [CI]=1.08 to 1.46, p=0.004).
A meta-analysis of four studies (N=507) using a continuous measure of depressive symptoms showed a similar effect of adjunctive L-methylfolate (standardized mean difference=- 0.38, 95% CI=- 0.59 to-0.17, p=0.0003).
Adjunctive L-methylfolate may have modest efficacy in antidepressant-treated adults with MDD.
3Negative symptoms in schizophreniaMeta-Analysen=925 · large study2018
Einfach gesagt: Our findings suggest that pooled FA + AP treatment improves negative symptoms in schizophrenia patients.
Sakuma K et al. · Psychopharmacology (2018)
Spürbar Nutzen
← SchlechterKein EffektBesser →
Likely real
Pooled FA + AP treatments were more effective than placebo + AP for negative symptoms (N = 5, n = 281; SMD = -0.25, 95% CI = -0.49, -0.01, p = 0.04, I2 = 0%).
Our findings suggest that pooled FA + AP treatment improves negative symptoms in schizophrenia patients.
Einfach gesagt: Based on the current data and clinician input, a range of nutraceuticals and phytoceuticals were given either a supportive recommendation or a provisional recommendation across a range of various psychiatric disorders.
Sarris J et al. · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry (2022)
Based on the current data and clinician input, a range of nutraceuticals and phytoceuticals were given either a supportive recommendation or a provisional recommendation across a range of various psychiatric disorders.
However several had only a weak endorsement for potential use; for a few it was not possible to reach a clear recommendation direction, largely due to mixed study findings; while some other agents showed no obvious therapeutic benefit and were clearly not recommended for use.
It is the intention of these guidelines to inform psychiatric/medical, and health professional practice globally.
9Clinical outcomes for psychiatric diseasesSystematische Übersichtn=23 · very small study2022
Einfach gesagt: Increasing evidence from clinical trials consistently demonstrate folate supplements, especially levomefolic acid or 5-methylfolate, may improve clinical outcomes for certain psychiatric diseases, especially as an adjunct pharmacotherapy with minimal side effects.
Increasing evidence from clinical trials consistently demonstrate folate supplements, especially levomefolic acid or 5-methylfolate, may improve clinical outcomes for certain psychiatric diseases, especially as an adjunct pharmacotherapy with minimal side effects.
10Cardiovascular disorders and depression preventionÜbersicht2024
Einfach gesagt: With regard to the prevention of cardiovascular disorders, available evidence is not conclusive.
Rubini M, Di Minno G, Ferrazzi E. · European review for medical and pharmacological sciences (2024)
Otherwise, the role of 5-MTHF in the management of cardiovascular risk is still debated due to the multiple confounding factors that characterize this patient setting.
A link between folate deficiency in pregnancy and postpartum depression has been proposed, as well as between folate levels and the onset of depression.
In conclusion, evidence from the literature supports the additional role of 5-MTHF as a pleiotropic drug with a transversal effect in different therapeutic contexts.
Einfach gesagt: Conclusions : Despite the potential value of 5-MTHF as an alternative to FA, clinical studies would be urgently needed to support the efficacy, dosage, timing, and/or safety of its use as a supplement.
However, more studies are definitely still needed to establish 5-MTHF as a safe and effective therapeutic approach comparable with FA.
Moreover, there is a lack of clinical studies that evaluate the efficacy of 5-MTHF supplementation in the prevention of NTDs.
The present evidence-based narrative review discusses differences between FA and 5-MTHF in terms of structure, metabolism, bioavailability, clinical efficacy, and safety.
Einfach gesagt: Finally, relevant nutritional guidelines are presented with their conclusion for the role of each nutrient in the management of depression.
Tobin D, Vuckovic A, Sarris J. · Nutrients (2024)
This paper provides a narrative review of three nutrients which have significant scientific support for the management of depression.
A deficiency in each nutrient is associated with depression, and interventional studies indicate that the correction of the nutritional deficiency may provide clinical benefit.
We present epidemiological evidence, a mechanistic explanation and a review of interventional studies for these nutrients.
Einfach gesagt: These evidence-based interventions aim to restore endothelial homeostasis, slow disease progression, and improve patient outcomes across a variety of disorders linked to poor vascular health.
Ayoub G. · Nutrients (2025)
Folate is noted for its central function in one-carbon metabolism and in converting homocysteine to methionine, thereby reducing vascular toxicity.
We cover natural dietary sources of folate, synthetic folic acid, and the biologically active forms 5-methyl-(6S)-tetrahydrofolate (L-5-MTHF, L-methylfolate) and 5-formyl-(6S)-tetrahydrofolate (levoleucovorin).
These evidence-based interventions aim to restore endothelial homeostasis, slow disease progression, and improve patient outcomes across a variety of disorders linked to poor vascular health.
Einfach gesagt: Our aim is to improve the identification of individuals at high risk of CAD and enhance their prognosis.
Pietruszyńska-Reszetarska A, Pietruszyński R, Irzmański R. · International journal of molecular sciences (2024)
This review explores the significance of the methylation pathway and folate metabolism in CAD pathogenesis, with a focus on endothelial dysfunction resulting from deficiency in the active form of folate (5-MTHF).
We discuss emerging areas of research into CAD biomarkers and factors influencing the methylation process.
By highlighting genetically determined methylation disorders, particularly the MTHFR polymorphism, we propose the potential use of the active form of folate (5-MTHF) as a novel CAD biomarker and personalized pharmaceutical for selected patient groups.
17Liver fat content (CAP)RCTn=155 · medium study2024
Einfach gesagt: These findings suggest that this supplementation regimen could be a beneficial adjunct therapy for improving liver health in adults with obesity-induced MASLD.
Perva IT et al. · Medicina (Kaunas, Lithuania) (2024)
Kaum spürbar Nutzen
← SchlechterKein EffektBesser →
Borderline
The treatment group exhibited a mean reduction in CAP of 4% (p < 0.05) and a mean reduction in TE of 7.8% (p < 0.05), indicative of a decline in liver fat content and fibrosis.
The administration of the nutritional supplement resulted in a notable reduction in both CAP and TE scores when compared to the placebo group.
Conclusions: The supplementation over a period of three months led to a significant amelioration of liver fibrosis and steatosis parameters in adults with metabolic syndrome and obesity.
18Subclinical depression symptomsRCTn=140 · medium study2023
Einfach gesagt: Conclusions: The received results confirm the available evidence for the properties of SAMe in depression and complement them with evidence of the ef-fectiveness of the Deprilium® complex that contains SAMe and L-methylfolate with methylcobalamin, which together produce pharmacological and clinical synergy to reduce the severity of subclinical depressive manifestations in patients with NCD.
Results: After 60 days a statistically significant difference was observed in all clinical indicators between the intervention group and the control group.
When comparing the indicators of the intervention group on the 1st and on the 60th day of the study, statistically significant changes (p <0.000) were observed in all three indicators.
Further studies of the effectiveness of the use of the Deprilium® complex in patients with NCD are required.